Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.22), $0.10 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $1.61 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.